Inactive Instrument

Meda AB

Equities

SE0000221723

Pharmaceuticals

End-of-day quote Nasdaq Stockholm Other stock markets
- ^SEK	-

2016	Meda : Mylan gets EU approval for Meda purchase, subject to conditions	RE
2016	Exclusive - Mylan to get EU green light for Swedish drugmaker deal: sources	RE

Rights Issue: 1 new share @ 61 SEK for 10 existing shares

November 11, 2014

Latest news about Meda AB

Meda : Mylan gets EU approval for Meda purchase, subject to conditions	16-07-20	RE
Exclusive - Mylan to get EU green light for Swedish drugmaker deal: sources	16-07-15	RE
Meda : EU regulators to rule on Mylan's $7.2 billion Meda bid by July 6	16-06-02	RE
Valeant Pharmaceuticals Intl : gives Pershing Square one board seat, adds two other directors	16-03-09	RE
Abbott Laboratories : Mylan to buy Swedish drugmaker Meda in $7.2 billion deal	16-02-10	RE
Meda : Swedish drug firm Meda nears deal to sell U.S. business - sources	16-01-15	RE
AbbVie : Shire ready to bow to AbbVie's increased $53 billion offer	14-07-14	RE
Abbott Laboratories : Mylan near multibillion-dollar deal for Abbott drug assets - sources	14-07-11	RE
Abbott Laboratories : Exclusive: Mylan near multibillion-dollar deal for Abbott drug assets - sources	14-07-11	RE
Banks vie for fees as Nordic deal scene ignites	14-05-15	RE
Actavis : Factbox - M&A frenzy transforming global pharma	14-05-06	RE
Actavis : M&A frenzy in healthcare sector	14-05-06	RE
Actavis : Pfizer's designs on AstraZeneca stir tax envy among rivals	14-05-01	RE
AstraZeneca : Bayer offers animal health assets, cash for Merck's OTC unit -sources	14-04-29	RE
Allergan : Exclusive - Allergan eyes new takeover bid for Shire: sources	14-04-28	RE
Allergan : Exclusive: Merck in final talks to sell consumer unit for near $14 billion - sources	14-04-26	RE
Allergan : Novartis, Valeant bids herald new deal-making era for pharma	14-04-22	RE
Momentum stocks sink; Nasdaq posts worst day since February	14-04-04	RE
Meda : Swedish drugmaker Meda spurns Mylan takeover approach	14-04-04	RE
Meda : Shares in Swedish drugmaker Meda halted on Mylan bid talk	14-04-04	RE
Pfizer Inc. : Teva, Sun Pharma to pay $2.15 billion to settle Pfizer patent suit	13-06-12	RE
United Parcel Service, Inc. : Severn Trent deal blow hits "merger arb" funds	13-06-12	RE
Sun Pharmaceutical Industries Limited : Sweden's Meda sale talks founder on valuation - source	13-06-05	RE
Sun Pharmaceutical Industries Limited : India's Sun Pharma in talks to buy Sweden's Meda for $5-$6 billion: sources	13-05-31	RE

Chart Meda AB

Duration

Period

More charts

Company Profile

Sector

Pharmaceuticals

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+24.35%	653B
NOVO NORDISK A/S	+25.81%	556B
JOHNSON & JOHNSON	-6.33%	354B
MERCK & CO., INC.	+19.90%	331B
ABBVIE INC.	+7.95%	296B
ASTRAZENECA PLC	+12.91%	233B
NOVARTIS AG	+5.09%	201B
ROCHE HOLDING AG	-9.86%	193B
AMGEN INC.	-6.47%	144B

Other Pharmaceuticals